Antibody therapy for rheumatoid arthritis.
High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...
Hovedforfatter: | Taylor, P |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2003
|
Lignende værker
-
Humanised monoclonal antibody therapy for rheumatoid arthritis.
af: Isaacs, J, et al.
Udgivet: (1992) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
af: Isaacs, J, et al.
Udgivet: (1992) -
Anti-cytokine therapy for rheumatoid arthritis.
af: Maini, R, et al.
Udgivet: (2000) -
Anti-TNFalpha therapy for rheumatoid arthritis: an update.
af: Taylor, P
Udgivet: (2003) -
Antikeratin antibodies in rheumatoid arthritis
af: J Zabek
Udgivet: (2003-02-01)